Benitec Biopharma Inc expected to post a loss of 78 cents a share - Earnings Preview

Benitec Biopharma

10/05/2024 13:18

* Benitec Biopharma Inc  BNTC.OQ   BNTC.O  is expected
to show a
fall in quarterly revenue when it reports  results on May 13
(estimated) for the period ending March 31 2024
    * 
    * ​LSEG's mean analyst estimate for Benitec Biopharma Inc is
for a
loss of 78 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Benitec
Biopharma
Inc is $16.00​, above​ its last closing price of $9.18. ​​​

This summary was machine generated May 10 at 12:18 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)